Erratum: Permissivity of primary human hepatocytes and different hepatoma cell lines to cell culture adapted hepatitis C virus (PLoS ONE (2013) 8:8 (e70809)DOI: 10.1371/journal.pone.0070809);Permissivity of Primary Human Hepatocytes and Different Hepatoma Cell Lines to Cell Culture Adapted Hepatitis C Virus

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Helle, Francois ^a   Brochot, Etienne ^a   Fournier, Carole ^a   Descamps, Véronique ^a   Izquierdo, Laure ^a   Hoffmann, Thomas W ^a   Morel, Virginie ^a   Herpe, Yves Edouard ^a   Bengrine, Abderrahmane ^a   Belouzard, Sandrine ^b,c   Wychowski, Czeslaw ^b,c   Dubuisson, Jean ^b,c   Francois, Catherine ^a   Regimbeau, Jean Marc ^a   Castelain, Sandrine ^a   Duverlie, Gilles ^a  

^a UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^b INSERM U1019   (France)

^c UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; IODIXANOL; PROTEIN RFP NLS IPS; UNCLASSIFIED DRUG; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; DENSITY GRADIENT; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; INNATE IMMUNITY; INTERFERON INDUCTION; LIVER CELL; MUTATIONAL ANALYSIS; NONHUMAN; PROGENY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TUMOR CELL CULTURE; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS MUTATION; VIRUS PARTICLE; VIRUS REPLICATION; WESTERN BLOTTING;

HEPATITIS C VIRUS;

EID: 84881087434     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0223022     Document Type: Erratum

References (57)

1. Lemon SM, Walker C, Alter MJ, Yi M (2007) Hepatitis C virus. In: Knipe DM, Howley PM, editors. Fields Virology. Philadelphia, Pa: Lippincott Williams & Wilkins. 1253-1304.
2. Kato T, Date T, Miyamoto M, Furusaka A, Tokushige K, et al. (2003) Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125: 1808-1817.
3. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11: 791-796.
4. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, et al. (2005) Complete replication of hepatitis C virus in cell culture. Science 309: 623-626.
5. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, et al. (2005) Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 102: 9294-9299.
6. Lindenbach BD, Meuleman P, Ploss A, Vanwolleghem T, Syder AJ, et al. (2006) Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc Natl Acad Sci USA 103: 3805-3809.
7. Gottwein JM, Scheel TK, Jensen TB, Lademann JB, Prentoe JC, et al. (2009) Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs. Hepatology 49: 364-377.
8. Scheel TK, Gottwein JM, Carlsen TH, Li YP, Jensen TB, et al. (2011) Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutations. J Virol 85: 2891-2906.
9. Murray CL, Rice CM, (2011) Turning hepatitis C into a real virus. Annu Rev Microbiol 65: 307-327.
10. Bartenschlager R, Penin F, Lohmann V, Andre P, (2011) Assembly of infectious hepatitis C virus particles. Trends Microbiol 19: 95-103.
11. Podevin P, Carpentier A, Pene V, Aoudjehane L, Carriere M, et al. (2010) Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes. Gastroenterology 139: 1355-1364.
12. Banaudha K, Orenstein JM, Korolnek T, St Laurent GC, (2010) Primary hepatocyte culture supports hepatitis C virus replication: a model for infection-associated hepatocarcinogenesis. Hepatology 51: 1922-1932.
13. Buck M, (2008) Direct infection and replication of naturally occurring hepatitis C virus genotypes 1, 2, 3 and 4 in normal human hepatocyte cultures. PLoS One 3: e2660.
14. Ploss A, Khetani SR, Jones CT, Syder AJ, Trehan K, et al. (2010) Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc Natl Acad Sci U S A 107: 3141-3145.
15. Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J, (1982) Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 42: 3858-3863.
16. MacNab GM, Alexander JJ, Lecatsas G, Bey EM, Urbanowicz JM, (1976) Hepatitis B surface antigen produced by a human hepatoma cell line. Br J Cancer 34: 509-515.
17. Aden DP, Fogel A, Plotkin S, Damjanov I, Knowles BB, (1979) Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 282: 615-616.
18. Park JG, Lee JH, Kang MS, Park KJ, Jeon YM, et al. (1995) Characterization of cell lines established from human hepatocellular carcinoma. Int J Cancer 62: 276-282.
19. Fogh J, Fogh JM, Orfeo T, (1977) One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59: 221-226.
20. Gluzman Y, (1981) SV40-transformed simian cells support the replication of early SV40 mutants. Cell 23: 175-182.
21. Biron-Andreani C, Raulet E, Pichard-Garcia L, Maurel P, (2010) Use of human hepatocytes to investigate blood coagulation factor. Methods Mol Biol 640: 431-445.
22. Dubuisson J, Hsu HH, Cheung RC, Greenberg HB, Russell DG, et al. (1994) Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol 68: 6147-6160.
23. Flint M, Maidens C, Loomis-Price LD, Shotton C, Dubuisson J, et al. (1999) Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J Virol 73: 6235-6244.
24. Jones CT, Catanese MT, Law LM, Khetani SR, Syder AJ, et al. (2010) Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system. Nat Biotechnol 28: 167-171.
25. Delgrange D, Pillez A, Castelain S, Cocquerel L, Rouillé Y, et al. (2007) Robust production of infectious viral particles in Huh-7 cells by introducing mutations in HCV structural proteins. J Gen Virol 88: 2495-2503.
26. Goueslain L, Alsaleh K, Horellou P, Roingeard P, Descamps V, et al. (2010) Identification of GBF1 as a cellular factor required for hepatitis C virus RNA replication. J Virol 84: 773-787.
27. Helle F, Vieyres G, Elkrief L, Popescu CI, Wychowski C, et al. (2010) Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions. J Virol 84: 11905-11915.
28. Castelain S, Descamps V, Thibault V, Francois C, Bonte D, et al. (2004) TaqMan amplification system with an internal positive control for HCV RNA quantitation. J Clin Virol 31: 227-234.
29. Descamps V, Op de Beeck A, Plassart C, Brochot E, Francois C, et al. (2012) Strong Correlation between Liver and Serum Levels of Hepatitis C Virus Core Antigen and RNA in Chronically Infected Patients. J Clin Microbiol 50: 465-468.
30. Vausselin T, Calland N, Belouzard S, Descamps V, Douam F, et al. (2013) The antimalarial ferroquine is an inhibitor of hepatitis C virus. Hepatology: in press.
31. Pokrovskii MV, Bush CO, Beran RK, Robinson MF, Cheng G, et al. (2011) Novel mutations in a tissue culture-adapted hepatitis C virus strain improve infectious-virus stability and markedly enhance infection kinetics. J Virol 85: 3978-3985.
32. Zhong J, Gastaminza P, Chung J, Stamataki Z, Isogawa M, et al. (2006) Persistent hepatitis C virus infection in vitro: coevolution of virus and host. J Virol 80: 11082-11093.
33. Zeisel MB, Fofana I, Fafi-Kremer S, Baumert TF, (2011) Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies. J Hepatol 54: 566-576.
34. Timpe JM, Stamataki Z, Jennings A, Hu K, Farquhar MJ, et al. (2008) Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology 47: 17-24.
35. Gottwein JM, Scheel TK, Hoegh AM, Lademann JB, Eugen-Olsen J, et al. (2007) Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses. Gastroenterology 133: 1614-1626.
36. Kang JI, Kim JP, Wakita T, Ahn BY, (2009) Cell culture-adaptive mutations in the NS5B gene of hepatitis C virus with delayed replication and reduced cytotoxicity. Virus Res 144: 107-116.
37. Takeda M, Ikeda M, Ariumi Y, Wakita T, Kato N, (2012) Development of hepatitis C virus production reporter-assay systems using two different hepatoma cell lines. J Gen Virol 93: 1422-1431.
38. Fournier C, Helle F, Descamps V, Morel V, Francois C, et al. (2013) Natural selection of adaptive mutations in non-structural genes increases trans-encapsidation of hepatitis C virus replicons lacking envelope protein genes. J Gen Virol: in press.
39. Pacini L, Graziani R, Bartholomew L, De Francesco R, Paonessa G, (2009) Naturally occurring hepatitis C virus subgenomic deletion mutants replicate efficiently in Huh-7 cells and are trans-packaged in vitro to generate infectious defective particles. J Virol 83: 9079-9093.
40. Marukian S, Andrus L, Sheahan TP, Jones CT, Charles ED, et al. (2011) Hepatitis C virus induces interferon-lambda and interferon-stimulated genes in primary liver cultures. Hepatology 54: 1913-1923.
41. Park H, Serti E, Eke O, Muchmore B, Prokunina-Olsson L, et al. (2012) IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection. Hepatology 56: 2060-2070.
42. Thomas E, Gonzalez VD, Li Q, Modi AA, Chen W, et al. (2012) HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons. Gastroenterology 142: 978-988.
43. Witte K, Witte E, Sabat R, Wolk K, (2010) IL-28A, IL-28B, and IL-29: promising cytokines with type I interferon-like properties. Cytokine Growth Factor Rev 21: 237-251.
44. Kambara H, Fukuhara T, Shiokawa M, Ono C, Ohara Y, et al. (2012) Establishment of a Novel Permissive Cell Line for the Propagation of Hepatitis C Virus by Expression of MicroRNA miR122. J Virol 86: 1382-1393.
45. Narbus CM, Israelow B, Sourisseau M, Michta ML, Hopcraft SE, et al. (2011) HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycle. J Virol 85: 12087-12092.
46. Sainz B Jr, Barretto N, Yu X, Corcoran P, Uprichard SL, (2012) Permissiveness of human hepatoma cell lines for HCV infection. Virol J 9: 30.
47. Thibault PA, Huys A, Dhillon P, Wilson JA, (2013) MicroRNA-122-dependent and-independent replication of Hepatitis C Virus in Hep3B human hepatoma cells. Virology 436: 179-190.
48. Han Q, Xu C, Wu C, Zhu W, Yang R, et al. (2009) Compensatory mutations in NS3 and NS5A proteins enhance the virus production capability of hepatitis C reporter virus. Virus Res 145: 63-73.
49. Kaul A, Woerz I, Meuleman P, Leroux-Roels G, Bartenschlager R, (2007) Cell culture adaptation of hepatitis C virus and in vivo viability of an adapted variant. J Virol 81: 13168-13179.
50. Russell RS, Meunier JC, Takikawa S, Faulk K, Engle RE, et al. (2008) Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus. Proc Natl Acad Sci USA 105: 4370-4375.
51. Scheel TK, Gottwein JM, Jensen TB, Prentoe JC, Hoegh AM, et al. (2008) Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization. Proc Natl Acad Sci U S A 105: 997-1002.
52. Mee CJ, Grove J, Harris HJ, Hu K, Balfe P, et al. (2008) Effect of cell polarization on hepatitis C virus entry. J Virol 82: 461-470.
53. Sainz B Jr, Barretto N, Uprichard SL, (2009) Hepatitis C virus infection in phenotypically distinct Huh7 cell lines. PLoS One 4: e6561.
54. Coulouarn C, Factor VM, Andersen JB, Durkin ME, Thorgeirsson SS, (2009) Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 28: 3526-3536.
55. Icard V, Diaz O, Scholtes C, Perrin-Cocon L, Ramiere C, et al. (2009) Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins. PLoS One 4: e4233.
56. Jammart B, Michelet M, Pecheur EI, Parent R, Bartosch B, et al. (2013) VLDL-producing and HCV-replicating HepG2 cells secrete no more LVP than VLDL-deficient Huh7.5 cells. J Virol: in press.
57. Forte TM, McCall MR, Knowles BB, Shore VG, (1989) Isolation and characterization of lipoproteins produced by human hepatoma-derived cell lines other than HepG2. J Lipid Res 30: 817-829.